(2S)-2-amino-3-phenylpropane-1,1-diol

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2S)-2-amino-3-phenylpropane-1,1-diol
• 化学式: C₉H₁₃NO₂
• 分子量: 167.208
• InChiKey: IFTWVTAUEXLCHB-QMMMGPOBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  66.5
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  L-苯丙氨酸 在 (R)-epinephrine dehydrogenase 、 还原型辅酶Ⅰ 作用下， 以 aq. phosphate buffer 为溶剂， 生成 (2S)-2-amino-3-phenylpropane-1,1-diol
  参考文献：
  名称：

  Purification and characterization of a novel carbonyl reductase involved in oxidoreduction of aromatic β-amino ketones/alcohols

  摘要：

  Aromatic beta-amino ketones/alcohols such as adrenalone play an important role in some stereoselective synthesis of pharmaceuticals. Unfortunately, the transformation of aromatic beta-amino ketones to their chiral alcohols has been carried out chemically as no corresponding biocatalyst has been available. Here, a novel carbonyl reductase responsible for the reduction of adrenalone to (R)-(-)-epinephrine was identified and characterized from Kocuria rhizophila. This enzyme was purified to homogeneity by ammonium sulfate precipitation followed by ion-exchange column chromatography, hydrophobic chromatography and gel chromatography. The purified enzyme yielded pure (R)-enantiomer product with high activity and utilized NADH as the cofactor. The enzyme had special significance by showing selectivity for many aromatic beta-amino ketones/alcohols such as 2-amino-acetophenone, 2-amino-4'-hydroxyacetophenone, isoproterenol and ephedrine. The maximum reaction rate (V-max) and apparent Michaelis-Menten constant (K-m) for adrenalone and NADH were 14.62 mu mol/(min mg) protein and 0.189 mM, 11.66 mu mol/(min mg) protein and 0.204 mM respectively. These properties ensure the enzyme a promising future for industrial application as a replacement of chemical synthesis of aromatic beta-amino chiral alcohols. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.procbio.2014.03.023

文献信息

• [EN] PREPARATION METHOD FOR DRUG-LINKER MC-MMAF USED FOR ANTIBODY DRUG CONJUGATES AND INTERMEDIATE THEREOF<br/>[FR] PROCÉDÉ DE PRÉPARATION DE MÉDICAMENT-LIEUR MC-MMAF UTILISÉ POUR DES CONJUGUÉS MÉDICAMENT-ANTICORPS ET INTERMÉDIAIRE DE CEUX-CI<br/>[ZH] 一种用于抗体药物偶联物的药物-连接子MC-MMAF的制备方法及其中间体
  申请人：LEVENA BIOPHARMA CO LTD

  公开号：WO2020181686A1

  公开（公告）日：2020-09-17

  本发明提供一种用于抗体偶联药物的药物-连接子MC-MMAF的制备方法及其中间体。本发明的制备方法提高了N端的反应活性，从而有效的控制了消旋反应的发生；不直接使用毒素MMAF，而采用毒性较低的化合物，降低了大量生产时的操作难度；无需反相制备，操作简便。
• IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS
  申请人：CAMP4 THERAPEUTICS CORPORATION

  公开号：US20210254056A1

  公开（公告）日：2021-08-19

  The present invention provides methods and compositions for the evaluation, alteration and/or optimization of gene signaling. Methods and systems are also provided which exploit the information generated in the identification of new targets and non-canonical signaling pathways.